EmboCube Gelatin Embolization to Control Bleeding or Hemorrhaging

CompletedOBSERVATIONAL
Enrollment

101

Participants

Timeline

Start Date

November 30, 2022

Primary Completion Date

March 15, 2024

Study Completion Date

April 10, 2024

Conditions
HemorrhageBleeding Hemorrhage
Interventions
DEVICE

EmboCube Embolization Gelatin

EmboCube is a uniformly cut gelatin foam pre-loaded into a syringe, indicated for use in embolization of blood vessels to occlude blood flow to control bleeding/hemorrhaging in the peripheral vasculature

Trial Locations (5)

2050

Chris O'Brien Lifehouse, Camperdown

Unknown

South Western Sydney Local Health District, Liverpool

Alfred Health, Sydney

Centre Hospitalier Universitaire de Nîmes - Caremeau, Nîmes

HEGP, Paris

Sponsors
All Listed Sponsors
lead

Merit Medical Systems, Inc.

INDUSTRY

NCT05307783 - EmboCube Gelatin Embolization to Control Bleeding or Hemorrhaging | Biotech Hunter | Biotech Hunter